ARTICLE | Management Tracks
Auspitz becomes managing partner at Curie.bio
Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more
January 15, 2025 12:43 AM UTC
Following Monday’s acquisition of Idrx Inc. by Gsk plc (LSE:GSK; NYSE:GSK), Idrx Chairman Ben Auspitz has become managing partner for series A fundings at Curie.bio. Auspitz served as Idrx’s CEO before becoming chairman in 2024, and co-founded the company with Curie.bio’s Alexis Borisy.
Amphista Therapeutics Ltd. named Paul Medeiros CBO. Medeiros was most recently president and CEO of Q-state Biosciences Inc. Amphista is developing targeted glues which combine the advantages of PROTACs and molecular glues...